ONCT-534 recruiting
ONCT-534 Earns FDA Fast Track Designa... - Advanced Prostate...
ONCT-534 Earns FDA Fast Track Designation in R/R Metastatic CRPC

Written by

Maxone73
To view profiles and participate in discussions please or .
5 Replies
•
Thanks. Their is still hope.
According to findings from preclinical studies, the agent has demonstrated activity in prostate cancer models with and without AR mutations.
Does not say what the basis for fast track is. Could it be more than mouse models?
it's for investigational drugs development, I thought it would happen after an incredibly promising start of phase 1, but it seems that the potential and the fact that it would be a lifesaver can be enough
from what I read they will sun a phase 1/2 instead of two separate phases
Good Luck, Good Health and Good Humor.
j-o-h-n Monday 10/30/2023 7:45 PM DST
My work of art............Little bastards having fun with my body.
Not what you're looking for?
You may also like...
I wish I could bring only good news but: ONCT-534 trial discontinued
We can't always win! 😐
"In the current study, interim Phase 1 results of ONCT-534 did not show...
ONCT-534 some trial data soon?
The company developing ONCT-534 will take part at Oppenheimer 34th Annual Healthcare Life...
FDA Fast Track Designation for 225Ac-FL-020 for mCRPCa
Another weapon, from Germany this time....ahhhh zee germanz! Actinium strikes again!
Phase 1 trial...
Olaparib Combo Improves PFS/Responses in Metastatic CRPC - from ASCO GU2024
I am not sure, they always mix BTCA 1/2 and ATM, but maybe I can find the data for ATM only...but...
Seviteronel (VT-464) - Durham's Innocrin Nabs FDA Fast Track OK for Prostate Cancer Drug
Does anyone know anything about this drug?
Seviteronel (VT-464) - Durham's Innocrin Nabs FDA Fast...